Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study-Reference-Cited by-同舟云学术

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

Published:2020-06 Issue: Volume:23 Page:100353
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Folschweiller Nicolas,Teixeira Julio,Joshi Smita,Goldani Luciano Z,Supparatpinyo Khuanchai,Basu Partha,Chotpitayasunondh Tawee,Chetchotisakd Ploenchan,Ruxrungtham Kiat,Roteli-Martins Cecilia,Grinsztejn Beatriz,Quintana Silvana Maria,Kumarasamy Nagalingeswaran,Poongulali Selvamuthu,Kulkarni Vinay,Lin Lan,Datta Sanjoy K,Descamps Dominique,Dodet Monique,Dubin Gary,Friel Damien,Hezareh Marjan,Karkada Naveen,Meric Camilleri Dorothee,Poncelet Sylviane,Salaun Bruno,Tavares-da-Silva Fernanda,Thomas-Jooris Florence,Struyf Frank

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. World Health Organization (WHO). Cancer fact sheets: cervical cancer. 2012. http://gco.iarc.fr/today/fact-sheets-cancers?cancer=16&type=0&sex=2 (accessed 21-08-2018).

2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide;Walboomers;J Pathol,1999

3. Epidemiologic classification of human papillomavirus types associated with cervical cancer;Munoz;New England J Med,2003

4. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol,2010

5. World Health Organization (WHO). Human papillomavirus vaccines: Who position paper, May 2017. http://www.who.int/wer/2017/wer9219/en/ (accessed 18-08-2018).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV;Vaccines;2023-06-05

2. Vaccine clinical trials with dynamic borrowing of historical controls: Two retrospective studies;Pharmaceutical Statistics;2023-01-06

3. Low human papillomavirus vaccine uptake among women engaged in HIV care in Ontario, Canada;Preventive Medicine;2022-11

4. Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis;eClinicalMedicine;2022-10

5. Advances in Infectious Disease Vaccine Adjuvants;Vaccines;2022-07-13